Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2005
06/15/2005EP1541144A1 Indometacin preparation for external use
06/15/2005EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof
06/15/2005EP1539941A2 Adzymes and uses thereof
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539796A1 Anti-inflammatory or anti-allergic androstane complexes
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539761A1 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
06/15/2005EP1539755A1 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors
06/15/2005EP1539753A2 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539731A1 Novel compounds
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539727A2 Compounds, compositions, and methods
06/15/2005EP1539725A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
06/15/2005EP1539718A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539709A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539707A1 Method and compounds for promoting healing and reducing inflammation
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539687A1 Substituted glycine derivatives for use as medicaments
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539179A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
06/15/2005EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539148A2 Bicifadine formulation
06/15/2005EP1539143A2 Leflunomide analogs for treating rheumatoid arthritis
06/15/2005EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
06/15/2005EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
06/15/2005EP1539131A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
06/15/2005EP1539127A1 Method of treating osteoarthritis
06/15/2005EP1539120A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea
06/15/2005EP1539113A2 Modified release ketoprofen dosage form
06/15/2005EP1538980A1 Devices and methodologies useful in body aesthetics
06/15/2005EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/15/2005EP1435937B1 Composition comprising paracetamol and a bitterness masking component
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1372669B1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
06/15/2005EP1326866B1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1299107B1 Highly concentrated stable meloxicam solutions
06/15/2005EP1290447B1 Peptide potentiation of acid-sensory ion channel in pain
06/15/2005EP1278530B1 Chemical modification of mammalian urine
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1244625B1 4-pyridinyl-n-acyl-l-phenylalanines
06/15/2005EP1232139B1 Nervonic acid derivatives, their preparation and use
06/15/2005EP1198255A4 Identification of compounds that modify transcriptional responses to hypoxia
06/15/2005EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP1007068B1 Process for preparing synthetic soil-extract materials and medicaments based thereon
06/15/2005EP1001979B1 Cyclic azapeptides with angiogenic effect
06/15/2005EP0994704B1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
06/15/2005EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628115A 哌啶衍生物 Piperidine derivatives
06/15/2005CN1628113A Substituted indoles as alpha-1 agonists
06/15/2005CN1628104A Quinazolinone derivatives and their use as CB agonists
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628099A Water soluble phenylglycine derivatives
06/15/2005CN1627970A Safety shield system for prefilled syringe
06/15/2005CN1627956A Compositions containing oat straw and willowherb extract
06/15/2005CN1627951A Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626552A Angiogenesis related molecules
06/15/2005CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application
06/15/2005CN1626533A Process for preparation of sulfonamide derivs. and crystals thereof
06/15/2005CN1626514A Method for preparing-4-bromine-7-methyl isatin
06/15/2005CN1626234A Chinese herbal medicine for treating wind dampness and hyperosteogeny
06/15/2005CN1626231A Chinese traditional medicine of diathermic tincture prepared from snake in use for activating blood, removing blood stasis, diminishing inflammation and relieving pain
06/15/2005CN1626223A Corypalis tablet and preparation method
06/15/2005CN1626207A Preparation including unique ingredient and fabricating method
06/15/2005CN1626187A Medical paste for rheumatism and bone ache
06/15/2005CN1626175A Big bitter gourd in application for preparing medication
06/15/2005CN1626168A Leadwort (white snowflake) preparation
06/15/2005CN1626167A Ginseng-scorpion medicinal wine for activating the channels and alleviating pain
06/15/2005CN1626152A Medication for treating ache
06/15/2005CN1626139A Medication in use for bacteriostasis and antiinflammation
06/15/2005CN1626126A Drop pills of healthy energy of wrinkled gianthyssop
06/15/2005CN1626080A Paracetamol Pseudoephedrine desintegration piece and preparation method
06/15/2005CN1626077A Treatment of nuerodegenerative diseases
06/15/2005CN1626072A Powder and injection preparation of new houttuynine sodium bisulfite and preparation method
06/15/2005CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
06/15/2005CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method